Basics BioXcel Therapeutics, Inc. IPO Date: March 5, 2018 Sector: Healthcare Industry: Biotech Market Cap: $9.71M Activated in VL: True Average Daily Range Avg Daily Range: $0.63 | 4.12% Avg Daily Range (30 D): $0.10 | 5.61% Avg Daily Range (90 D): $0.12 | 7.11% Institutional Daily Volume Avg Daily Volume: .68M Avg Daily Volume (30 D): .09M Avg Daily Volume (90 D): 3.13M Trade Size Avg Trade Size (Sh.): 128 Avg Trade Size (Sh.) (30 D): 213 Avg Trade Size (Sh.) (90 D): 262 Institutional Trades Total Inst.Trades: 897 Avg Inst. Trade: $1.45M Avg Inst. Trade (30 D): $.6M Avg Inst. Trade (90 D): $.6M Avg Inst. Trade Volume: M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.56M Avg Closing Trade (30 D): $2.34M Avg Closing Trade (90 D): $2.34M Avg Closing Volume: 3.96K         News Apr 28, 2025 @ 5:00 PM Evolving Landscape of Mental Health Segment: Key M... Source: Delveinsight Mar 11, 2025 @ 11:00 AM BioXcel Therapeutics Strengthens Cash Position to ... Source: Bioxcel Therapeutics, Inc. Nov 21, 2024 @ 9:47 PM BioXcel Therapeutics Announces Proposed Public Off... Source: Globe Newswire Nov 21, 2024 @ 9:47 PM BioXcel Therapeutics Announces Proposed Public Off... Source: N/A Jul 16, 2024 @ 11:02 AM BioXcel Therapeutics Announces Preliminary Estimat... Source: Bioxcel Therapeutics, Inc. Financials   TTM Q4 2024 FY 2024 Basic EPS $-23.51 $-22.22 $-23.51 Diluted EPS $-23.51 $-22.22 $-23.51 Revenue $ 2.27M $ .37M $ 2.27M Gross Profit $ .12M $ -.47M $ .12M Net Income / Loss $ -59.6M $ -10.86M $ -59.6M Operating Income / Loss $ -67.25M $ -10.49M $ -67.25M Cost of Revenue $ 2.14M $ .83M $ 2.14M Net Cash Flow $ M $ M $ M PE Ratio     Splits Feb 10, 2025:   16:1